Skip to content
knowrare
HealthSignal
Your condition community

Living with Variant ABeta2M amyloidosis

A rare inherited condition in which an abnormal protein builds up in the body, affecting the gut, nerves, and kidneys.

Understanding Variant ABeta2M amyloidosis

Variant ABeta2M amyloidosis is a rare form of amyloidosis in which a changed form of the beta 2 microglobulin protein builds up in the body.

It mainly affects adults. GARD says the buildup leads to gradually worsening digestive problems, Sjogren syndrome (dry eyes and mouth), and autonomic neuropathy (nerve problems that affect automatic body functions).

Signs & symptoms

Symptoms vary from person to person. GARD lists these among the most common:

  • Chronic kidney disease
  • Protein buildup in the kidneys (renal amyloidosis)
  • Nerve squeezing in the wrist (median neuropathy)
  • Digestive problems
  • Dry eyes and mouth (Sjogren syndrome)
  • Automatic nerve problems

Not everyone has every symptom. GARD's list comes from the Human Phenotype Ontology.

Diagnosis

  1. Talk with your doctor

    Share the symptoms you've noticed, when they started and your family health history. Notes and photos can help.

  2. See a specialist

    Specialists who may be involved include autoimmune and inflammatory disease specialists and genetic specialists.

  3. Consider genetic testing

    Changes in B2M are linked to this condition. Genetic testing and counseling can help confirm a diagnosis and explain what it means for your family.

  4. Connect with expert centers

    Amyloidosis Foundation may keep lists of experts for this condition.

Care & treatment

Care team
autoimmune and inflammatory disease specialists (rheumatologists); Genetic specialists (geneticists)
Expert care
Expert lists: Amyloidosis Foundation
Treatment
GARD doesn't list specific treatments for this condition. Your care team will tailor care to your symptoms.
Research
Clinical trials and observational studies may be options. See the research section below.

General information, not medical advice. Your care team makes the decisions.

Everyday life

Living with a rare condition is easier with support.

  • Connect with Amyloidosis Foundation
  • Keep notes on symptoms, changes and questions for appointments
  • Ask about patient registries that help research
  • Look into financial aid and travel resources for care visits
Bring these questions to your next doctor visit
Could B2M genetic testing help our family?
How can my kidneys and digestion be monitored?
Which specialists should be on my care team?

Quick facts

Symptoms usually startAdult
InheritanceAutosomal Dominant
GenesB2M

This condition is caused by changes in the B2M gene. A child can get it from one parent with the changed gene (autosomal dominant).

Genetic

Also known as: autosomal dominant beta2-microglobulinic amyloidosis

Patient organizations

Source: NIH GARD · Variant ABeta2M amyloidosisGARD ID 21382 · GARD page updated September 2026 · Plain-language summary by Know Rare; editorial review pending. General information, not medical advice.

You are more than your diagnosis

Perspectives from people navigating life with Variant ABeta2M amyloidosis.

Explore the Variant ABeta2M amyloidosis blog

Explore research for Variant ABeta2M amyloidosis

Explore actively recruiting Variant ABeta2M amyloidosis studies with HealthSpark.

HealthSpark

Find actively recruiting studies for Variant ABeta2M amyloidosis with HealthSpark. Share your city to explore research near you.

  • Recruiting studies from ClinicalTrials.gov
  • Share your city to look for research near you
  • Eligibility is confirmed by the study team

Powered by HealthSpark, our AI chat helper

I can help you find recruiting Variant ABeta2M amyloidosis studies. Enter a ZIP code, address or city below and I'll look within 50 miles.

Powered by HealthSpark, our AI chat helper · Study information from ClinicalTrials.gov · Eligibility is confirmed by the study team.

Get Signals for Variant ABeta2M amyloidosis

Stay in the loop with community stories and updates from medical researchers.

HealthStoryfor Variant ABeta2M amyloidosis

Create a living journal that talks back

HealthStory evolves private journaling with a living AI journal that talks back and asks thoughtful questions, helping you capture your Variant ABeta2M amyloidosis experiences more deeply and prepare for better conversations with your doctors and care team.

Start your journal

Your journal is private. Sharing your story publicly is a separate choice, made with Share your story above.